| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1023477G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0123477 |
| P932 | PMC publication ID | 4418743 |
| P698 | PubMed publication ID | 25938589 |
| P5875 | ResearchGate publication ID | 276144747 |
| P2093 | author name string | Ming Zhang | |
| Jie Du | |||
| Li-Ping Liu | |||
| Shao-Ping Nie | |||
| Yasushi Matsuzawa | |||
| Hai Gao | |||
| Duo Guo | |||
| Li-Xiao Su | |||
| Raviteja Reddy Guddeti | |||
| P2860 | cites work | miR-145 and miR-143 regulate smooth muscle cell fate and plasticity | Q24311186 |
| MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation | Q24650539 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? | Q26992023 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation | Q28269643 | ||
| Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
| Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis | Q30433361 | ||
| Role of smooth muscle cells in the initiation and early progression of atherosclerosis | Q30438867 | ||
| Pathophysiology of coronary artery disease | Q34429470 | ||
| MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease | Q35007985 | ||
| Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? | Q35033686 | ||
| Cardiovascular remodelling in coronary artery disease and heart failure | Q35090566 | ||
| Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability | Q36752100 | ||
| Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction | Q37662409 | ||
| Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing | Q37945163 | ||
| Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? | Q37981140 | ||
| MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? | Q38074511 | ||
| Pathogenic arterial remodeling: the good and bad of microRNAs | Q38080410 | ||
| Circulating miRNAs: novel biomarkers of acute coronary syndrome? | Q38095110 | ||
| Major causes of death among men and women in China | Q39061262 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| The SYNTAX score and its clinical implications | Q46105337 | ||
| Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. | Q51344612 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| MicroRNA-145 Targeted Therapy Reduces Atherosclerosis | Q57174543 | ||
| Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease | Q61668954 | ||
| MicroRNAs in vascular biology – metabolism and atherosclerosis | Q63915727 | ||
| Diagnostic quantification of CASS (coronary artery surgery study) clinical and exercise test results in determining presence and extent of coronary artery disease. A multivariate approach | Q71508548 | ||
| Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data | Q72561659 | ||
| Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling | Q73414054 | ||
| Population trends in the incidence and outcomes of acute myocardial infarction | Q84431288 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| coronary artery disease | Q844935 | ||
| P304 | page(s) | e0123477 | |
| P577 | publication date | 2015-05-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease | |
| P478 | volume | 10 |
| Q37624915 | Circular RNAs in Cardiovascular Disease: An Overview. |
| Q42321217 | Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease |
| Q42370383 | Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury |
| Q94596857 | Circulating plasma microRNA-126, microRNA-145, and microRNA-155 and their association with atherosclerotic plaque characteristics |
| Q42464572 | Correction: Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease |
| Q33816293 | Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia |
| Q64227247 | Identification of Candidate Genes and MicroRNAs for Acute Myocardial Infarction by Weighted Gene Coexpression Network Analysis |
| Q26746063 | Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review |
| Q49379816 | MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload |
| Q26765152 | Novel epigenetic-based therapies useful in cardiovascular medicine |
| Q36936744 | Plasma MicroRNA-21 Predicts Postoperative Pulmonary Complications in Patients Undergoing Pneumoresection |
| Q97520523 | Plasma-Derived Exosomal Circular RNA hsa_circ_0005540 as a Novel Diagnostic Biomarker for Coronary Artery Disease |
| Q26739721 | Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease |
| Q42330837 | The role of circulating microRNAs in acute coronary syndromes: ready for prime time? |
| Q99404614 | Value of Blood-Based microRNAs in the Diagnosis of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis |
| Q92305993 | Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction |
| Q37726680 | miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study. |
Search more.